NasdaqGS:MPLTBiotechs
Assessing MapLight Therapeutics (MPLT) Valuation After Strong Recent Share Price Momentum
MapLight Therapeutics stock reaction
MapLight Therapeutics (MPLT) has drawn investor attention after recent trading, with the stock at $29.31 and showing sharp moves over the past 3 months alongside mixed short term returns.
See our latest analysis for MapLight Therapeutics.
For context, the 1-day share price return declined 1.58%, while the 90-day share price return of 66.53% and year to date share price return of 74.78% point to strong recent momentum despite a softer 30-day share price...